and identified the BMP-Smad 1/5/8 and activin-Smad 2/3 pathways as potential targets for drug development. Sotatercept, approved in 2024 in the United States and Europe, was shown in clinical trials ...
The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...
The U.S. patient population for Revuforj in its approved indication is roughly 2,000 according to Syndax. KMT2A leukemias ...
The Food and Drug Administration approved on Friday a new drug developed by Syndax Pharmaceuticals to treat patients with a ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs).
Counties are colored red or blue when the % expected vote reporting reaches a set threshold. This threshold varies by state and is based on patterns of past vote reporting and expectations about ...
Interaksyon on MSN23m
‘Right of every Filipino’: Generic brand advocates for affordable healthcareHealthcare products provider RHEA Generics is committed to promoting affordable healthcare by offering generic medications ...
Slot has been backed to take a second managerial role at the expense of Ten Hag after a Dutch source delivered a scathing assessment of Ten Hag's capabilities following his divisive Man Utd spell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback